137 related articles for article (PubMed ID: 18819982)
1. Non-susceptibility trends among enterococci and non-pneumococcal streptococci from bacteraemias in the UK and Ireland, 2001-06.
Brown DF; Hope R; Livermore DM; Brick G; Broughton K; George RC; Reynolds R;
J Antimicrob Chemother; 2008 Nov; 62 Suppl 2():ii75-85. PubMed ID: 18819982
[TBL] [Abstract][Full Text] [Related]
2. Antimicrobial susceptibility of the pathogens of bacteraemia in the UK and Ireland 2001-2002: the BSAC Bacteraemia Resistance Surveillance Programme.
Reynolds R; Potz N; Colman M; Williams A; Livermore D; MacGowan A;
J Antimicrob Chemother; 2004 Jun; 53(6):1018-32. PubMed ID: 15128723
[TBL] [Abstract][Full Text] [Related]
3. Non-susceptibility trends and serotype distributions among Streptococcus pneumoniae from community-acquired respiratory tract infections and from bacteraemias in the UK and Ireland, 1999 to 2007.
Farrell DJ; Felmingham D; Shackcloth J; Williams L; Maher K; Hope R; Livermore DM; George RC; Brick G; Martin S; Reynolds R;
J Antimicrob Chemother; 2008 Nov; 62 Suppl 2():ii87-95. PubMed ID: 18819983
[TBL] [Abstract][Full Text] [Related]
4. Non-susceptibility trends among Pseudomonas aeruginosa and other non-fermentative Gram-negative bacteria from bacteraemias in the UK and Ireland, 2001-06.
Livermore DM; Hope R; Brick G; Lillie M; Reynolds R;
J Antimicrob Chemother; 2008 Nov; 62 Suppl 2():ii55-63. PubMed ID: 18819980
[TBL] [Abstract][Full Text] [Related]
5. Drug susceptibility testing of clinical isolates of streptococci and enterococci by the Phoenix automated microbiology system.
Brigante GR; Luzzaro FA; Pini B; Lombardi G; Sokeng G; Toniolo AQ
BMC Microbiol; 2007 May; 7():46. PubMed ID: 17521437
[TBL] [Abstract][Full Text] [Related]
6. Non-susceptibility trends among staphylococci from bacteraemias in the UK and Ireland, 2001-06.
Hope R; Livermore DM; Brick G; Lillie M; Reynolds R;
J Antimicrob Chemother; 2008 Nov; 62 Suppl 2():ii65-74. PubMed ID: 18819981
[TBL] [Abstract][Full Text] [Related]
7. Non-susceptibility trends among Haemophilus influenzae and Moraxella catarrhalis from community-acquired respiratory tract infections in the UK and Ireland, 1999-2007.
Morrissey I; Maher K; Williams L; Shackcloth J; Felmingham D; Reynolds R;
J Antimicrob Chemother; 2008 Nov; 62 Suppl 2():ii97-103. PubMed ID: 18819984
[TBL] [Abstract][Full Text] [Related]
8. Non-susceptibility trends among Enterobacteriaceae from bacteraemias in the UK and Ireland, 2001-06.
Livermore DM; Hope R; Brick G; Lillie M; Reynolds R;
J Antimicrob Chemother; 2008 Nov; 62 Suppl 2():ii41-54. PubMed ID: 18819979
[TBL] [Abstract][Full Text] [Related]
9. [Update on the susceptibility of streptococci to antibiotics (enterococci and Streptococcus pneumoniae excluded)].
Faibis F; Fiacre A; Demachy MC
Ann Biol Clin (Paris); 2003; 61(1):49-59. PubMed ID: 12604386
[TBL] [Abstract][Full Text] [Related]
10. [Antibiotics susceptibility of Streptococcus and Enterococcus: data of Onerba network].
Vachée A; Varon E; Jouy E; Meunier D;
Pathol Biol (Paris); 2009 May; 57(3):240-4. PubMed ID: 18343047
[TBL] [Abstract][Full Text] [Related]
11. In vitro activity of linezolid as assessed through the 2013 LEADER surveillance program.
Flamm RK; Mendes RE; Hogan PA; Ross JE; Farrell DJ; Jones RN
Diagn Microbiol Infect Dis; 2015 Apr; 81(4):283-9. PubMed ID: 25633420
[TBL] [Abstract][Full Text] [Related]
12. Antimicrobial susceptibility of gram-positive bacteria isolated from European medical centres: results of the Daptomycin Surveillance Programme (2002-2004).
Sader HS; Streit JM; Fritsche TR; Jones RN
Clin Microbiol Infect; 2006 Sep; 12(9):844-52. PubMed ID: 16882289
[TBL] [Abstract][Full Text] [Related]
13. Antimicrobial resistance of enterococci in Turkey.
Kaçmaz B; Aksoy A
Int J Antimicrob Agents; 2005 Jun; 25(6):535-8. PubMed ID: 15908184
[TBL] [Abstract][Full Text] [Related]
14. In vitro activity of telavancin and comparators against selected groups of Gram-positive cocci.
Hope R; Chaudhry A; Adkin R; Livermore DM
Int J Antimicrob Agents; 2013 Mar; 41(3):213-7. PubMed ID: 23298432
[TBL] [Abstract][Full Text] [Related]
15. Phenotypes and genotypes of vancomycin-resistant enterococci isolated during long-term follow-up in a patient with recurrent bacteremia and colonization.
Yeh KM; Lu JJ; Siu LK; Peng MY; Chang FY
J Microbiol Immunol Infect; 2002 Dec; 35(4):243-8. PubMed ID: 12542250
[TBL] [Abstract][Full Text] [Related]
16. In vitro activity of oritavancin and comparator agents against staphylococci, streptococci and enterococci from clinical infections in Europe and North America, 2011-2014.
Biedenbach DJ; Arhin FF; Moeck G; Lynch TF; Sahm DF
Int J Antimicrob Agents; 2015 Dec; 46(6):674-81. PubMed ID: 26541881
[TBL] [Abstract][Full Text] [Related]
17. Antimicrobial susceptibility of lower respiratory tract pathogens in Great Britain and Ireland 1999-2001 related to demographic and geographical factors: the BSAC Respiratory Resistance Surveillance Programme.
Reynolds R; Shackcloth J; Felmingham D; MacGowan A;
J Antimicrob Chemother; 2003 Dec; 52(6):931-43. PubMed ID: 14585865
[TBL] [Abstract][Full Text] [Related]
18. Antimicrobial susceptibility of Gram-positive bacterial isolates from the Asia-Pacific region and an in vitro evaluation of the bactericidal activity of daptomycin, vancomycin, and teicoplanin: a SENTRY Program Report (2003-2004).
Biedenbach DJ; Bell JM; Sader HS; Fritsche TR; Jones RN; Turnidge JD
Int J Antimicrob Agents; 2007 Aug; 30(2):143-9. PubMed ID: 17531446
[TBL] [Abstract][Full Text] [Related]
19. Survey, laboratory and statistical methods for the BSAC Resistance Surveillance Programmes.
Reynolds R; Hope R; Williams L;
J Antimicrob Chemother; 2008 Nov; 62 Suppl 2():ii15-28. PubMed ID: 18819976
[TBL] [Abstract][Full Text] [Related]
20. Australian Group on Antimicrobial Resistance Enterococcus Surveillance Programme annual report, 2010.
Coombs GW; Pearson JC; Christiansen K; Gottlieb T; Bell JM; George N; Turnidge JD;
Commun Dis Intell Q Rep; 2013 Sep; 37(3):E199-209. PubMed ID: 24890955
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
